AZmed is a French startup that has made significant strides in the field of AI-powered radiology software. The company's mission is to address the imbalance between the increasing number of medical imaging acts and the stagnation of specialists available to analyze the growing volume of information. AZmed's AI technology enables doctors to streamline trauma and chest X-ray diagnostics, ultimately saving time and resources for critical exams. This solution has already been adopted in over 2500 healthcare institutions and is regularly used by more than 9000 doctors across 55 countries and 5 continents. The company's focus on low-level exams has allowed doctors to improve daily productivity and optimize their workflows without disrupting their established practices. This has caught the attention of investors, leading to a recent €15.00M Series A investment from notable firms such as Techstars, Teampact Ventures, and Maison Worms. With its CE-marked IIa (under MDR 2017/45) and FDA-cleared product, AZmed is well-positioned to revolutionize the future of medical imaging.